Loading...
XSTOBIOT
Market cap1.15bUSD
Dec 23, Last price  
160.70SEK
1D
0.63%
1Q
-11.46%
Jan 2017
250.11%
Name

Biotage AB

Chart & Performance

D1W1MN
XSTO:BIOT chart
P/E
51.86
P/S
6.85
EPS
3.10
Div Yield, %
0.83%
Shrs. gr., 5y
2.72%
Rev. gr., 5y
15.37%
Revenues
1.86b
+18.90%
366,649,000430,396,000519,497,000496,402,000385,295,000394,123,000428,926,000428,408,000462,941,000444,645,000490,381,000610,534,000667,912,000748,147,000910,896,0001,101,373,0001,092,278,0001,232,000,0001,566,000,0001,862,000,000
Net income
246m
-8.21%
-115,021,000-39,892,0002,816,00099,373,000299,054,00013,478,000-410,243,00032,475,00038,336,00041,392,00051,112,00073,255,00092,796,000138,747,000167,627,000186,820,000175,000,000205,000,000268,000,000246,000,000
CFO
284m
-16.72%
-97,886,000-20,291,00039,908,00033,718,00088,737,00036,248,00057,595,000109,049,00074,472,00056,757,00080,906,000120,078,000139,072,000168,932,000155,005,000211,807,000279,047,000353,000,000341,000,000284,000,000
Dividend
Apr 26, 20241.6 SEK/sh
Earnings
Feb 19, 2025

Profile

Biotage AB (publ) provides separation technologies in the areas of organic and analytical chemistry, biomolecules, and industrial scale up applications. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems and flash system accessories; normal, reversed, and speciality phase cartridges; plasmid purification solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, and government authorities and academic institutions, as well as clinical, forensic, and academic laboratories. It operates in 70 countries, which include Americas, Europe, the Middle East, Africa, and Asia Pacific. Biotage AB (publ) was founded in 1969 and is headquartered in Uppsala, Sweden.
URL
https://www.biotage.com/
IPO date
Jun 30, 2000
Employees
527
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
1,862,000
18.90%
1,566,000
27.11%
1,232,000
12.79%
Cost of revenue
1,580,000
1,256,000
972,000
Unusual Expense (Income)
NOPBT
282,000
310,000
260,000
NOPBT Margin
15.15%
19.80%
21.10%
Operating Taxes
57,000
80,000
64,000
Tax Rate
20.21%
25.81%
24.62%
NOPAT
225,000
230,000
196,000
Net income
246,000
-8.21%
268,000
30.73%
205,000
17.14%
Dividends
(106,000)
(102,000)
(98,000)
Dividend yield
1.07%
0.83%
0.57%
Proceeds from repurchase of equity
2,000
BB yield
-0.02%
Debt
Debt current
33,000
25,000
23,000
Long-term debt
335,000
259,000
233,000
Deferred revenue
55,000
Other long-term liabilities
150,000
22,000
(1,000)
Net debt
(241,000)
(172,000)
(69,000)
Cash flow
Cash from operating activities
284,000
341,000
353,000
CAPEX
(26,000)
(70,000)
(56,000)
Cash from investing activities
35,000
(84,000)
(341,000)
Cash from financing activities
(142,000)
(133,000)
(82,000)
FCF
74,000
170,000
183,794
Balance
Cash
594,000
441,000
311,000
Long term investments
15,000
15,000
14,000
Excess cash
515,900
377,700
263,400
Stockholders' equity
1,366,000
1,356,000
1,155,000
Invested Capital
3,550,100
1,498,300
1,365,600
ROIC
8.91%
16.06%
17.56%
ROCE
6.62%
15.92%
15.28%
EV
Common stock shares outstanding
73,994
66,184
65,465
Price
133.70
-27.92%
185.50
-29.20%
262.00
88.49%
Market cap
9,893,056
-19.42%
12,277,192
-28.42%
17,151,779
89.23%
EV
9,652,056
12,105,192
17,132,779
EBITDA
404,000
412,000
335,000
EV/EBITDA
23.89
29.38
51.14
Interest
11,000
5,000
3,000
Interest/NOPBT
3.90%
1.61%
1.15%